Mouse IGFBP6 enzyme-linked immunoassay kit

CAT: EM0085 Datasheet
Specification 96 Test
Sensitivity 12.47 pg/ml (10 μl)
Standard Curve Range 156.25 ~10000 pg/ml
Standard Curve Gradient 7 Points
Number of Incubations 2
Detectable sample Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc.
Sample Volume 10 μl
Type Fully Ready-to-Use
Operation Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0509 0.0496 0.0503
156.25 0.1246 0.1145 0.1196 0.0693
312.50 0.1860 0.1937 0.1899 0.1396
625.00 0.3514 0.3276 0.3395 0.2893
1250.00 0.6322 0.6298 0.6310 0.5808
2500.00 1.1910 1.2870 1.2390 1.1888
5000.00 2.3440 2.4260 2.3850 2.3348
10000.00 4.1115 4.1452 4.1284 4.0781

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(pg/ml) 199.3 1019.4 3084.6 209.7 1048.7 3142.2
Standard Deviation 11.9 50.8 169.7 11.8 39.6 74.9
Coefficient of Variation(%) 6.0 5.0 5.5 5.6 3.8 2.4

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of mouse IGFBP6 into health mouse serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 85% to 112% with an overall mean recovery of 97%.

Sample Values

Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Serum3020.32-78.8010044.47

Serum/Plasma – Thirty samples from apparently healthy mice were evaluated for the presence of mouse IGFBP6 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: IGFBP6

The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-transitional modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. Human IGFBP-6 cDNA encodes a 240 amino acid (aa) residue precursor protein with a putative 24 aa residue signal peptide that is processed to generate the 216 aa residue mature protein that is O-glycosylated. IGFBP-6 is expressed in ovarian cells, prostatic cells, and fibroblasts. IGFBP-6 is found predominantly in CSF and serum. IGFBP-6 binds preferentially to IGF-II, exhibiting a 2-fold higher affinity for IGF-II than for IGF-I.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee